{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhang K"],"funding":["China National Funds for Distinguished Young Scientists"],"pagination":["1661"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11829982"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(1)"],"pubmed_abstract":["Fibroblast growth factor 21 (FGF21), a metabolic hormone with pleiotropic effects, is beneficial for various cardiac disorders. However, FGF21's role in heart failure with preserved ejection fraction (HFpEF) remains unclear. Here, we show that elevated circulating FGF21 levels are negatively associated with cardiac diastolic function in patients with HFpEF. Global or adipose FGF21 deficiency exacerbates cardiac diastolic dysfunction and damage in high-fat diet (HFD) plus N<sup>[w]</sup>-nitro-L-arginine methyl ester (L-NAME)-induced HFpEF mice, whereas these effects are notably reversed by FGF21 replenishment. Mechanistically, FGF21 enhances the production of adiponectin (APN), which in turn indirectly acts on cardiomyocytes, or FGF21 directly targets cardiomyocytes, to negatively regulate"],"journal":["Nature communications"],"pubmed_title":["FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice."],"pmcid":["PMC11829982"],"funding_grant_id":["81925004"],"pubmed_authors":["Yang J","Zhang K","Wang B","Zhen D","Gan J","Lin Z","Wu F","Liu X","Wang N","Li X","Li Y","Xu A","Lei W","Wen C","Gao X"],"additional_accession":[]},"is_claimable":false,"name":"FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice.","description":"Fibroblast growth factor 21 (FGF21), a metabolic hormone with pleiotropic effects, is beneficial for various cardiac disorders. However, FGF21's role in heart failure with preserved ejection fraction (HFpEF) remains unclear. Here, we show that elevated circulating FGF21 levels are negatively associated with cardiac diastolic function in patients with HFpEF. Global or adipose FGF21 deficiency exacerbates cardiac diastolic dysfunction and damage in high-fat diet (HFD) plus N<sup>[w]</sup>-nitro-L-arginine methyl ester (L-NAME)-induced HFpEF mice, whereas these effects are notably reversed by FGF21 replenishment. Mechanistically, FGF21 enhances the production of adiponectin (APN), which in turn indirectly acts on cardiomyocytes, or FGF21 directly targets cardiomyocytes, to negatively regulate","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Feb","modification":"2025-04-04T08:25:49.433Z","creation":"2025-04-04T08:25:49.433Z"},"accession":"S-EPMC11829982","cross_references":{"pubmed":["39955281"],"doi":["10.1038/s41467-025-56885-9"]}}